Clinical Study

Predictors of Venous Thromboembolic Events Associated with Central Venous Port Insertion in Cancer Patients

Table 2

Incidence of thrombotic events at 3 months and 12 months (proportion and CI95).

3 months
12 months
All eventsSymptomatic eventsAll eventsSymptomatic events

Subclavian DVT3.0% (1.9–4.0)2.1% (1.2–3.1)5.9% (4.5–7.8)4.1% (2.7–5.4)
PE3.0% (1.9–4.0)1.4% (0.7–2.1)5.5% (4.1–6.9)2.7% (1.6–3.7)
Catheter-related event (subclavian DVT or PE)5.9% (4.4–7.3)3.6% (2.4–4.7)11.3% (9.4–13.2)6.7% (5.1–8.4)
Lower extremity or visceral DVT2.2% (1.3–3.1)1.3% (0.6–2.1)4.6% (3.3–5.9)2.8% (1.7–3.9)
All thrombotic events7.6% (6.0–9.3)4.7% (3.4–6.0)15.3% (13.1–17.6)9.3% (7.3–11.2)